Dermatology Services for Seniors: Skin Cancer, Wound Care, and Aging Skin

Dermatology services for older adults address a distinct cluster of conditions shaped by decades of cumulative sun exposure, immune senescence, reduced epidermal regeneration, and the dermatologic side effects of chronic disease treatment. This page covers the principal categories of geriatric dermatologic care — skin cancer screening and treatment, chronic wound management, and age-related skin changes — along with the regulatory and coverage frameworks that govern how these services are delivered. Understanding the scope and structure of elder dermatology informs navigation of clinical pathways, Medicare reimbursement categories, and safety-relevant thresholds.

Definition and scope

Geriatric dermatology is the subspecialty branch of dermatology focused on skin, hair, and nail conditions that are disproportionately prevalent in adults aged 65 and older. The American Academy of Dermatology (AAD) identifies skin cancer as the most commonly diagnosed cancer in the United States, with incidence rising sharply after age 50 (AAD, Skin Cancer Resource Center). Adults over 65 account for a substantial fraction of all melanoma diagnoses, and non-melanoma skin cancers — primarily basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) — are even more concentrated in this population.

Beyond malignancy, the geriatric skin exhibits structural changes that generate independent clinical concerns. Epidermal thinning, reduced sebaceous output, diminished subcutaneous fat, and impaired barrier function all increase susceptibility to mechanical trauma, infection, and chronic wounds. Conditions such as xerosis (pathological dry skin), pruritus, seborrheic dermatitis, and stasis dermatitis require ongoing dermatologic management that intersects with chronic disease management, including diabetes and venous insufficiency.

Medicare coverage of dermatology services falls under Medicare Part B (outpatient physician services), with specific Current Procedural Terminology (CPT) codes governing biopsy, excision, Mohs micrographic surgery, and wound debridement. The Centers for Medicare & Medicaid Services (CMS) publishes applicable reimbursement rules in the Physician Fee Schedule (CMS Physician Fee Schedule).

How it works

Dermatologic care for seniors proceeds through four structured phases:

  1. Screening and early detection — Full-body skin examinations identify actinic keratoses (precancerous lesions), suspicious pigmented lesions, and early-stage non-melanoma cancers. The U.S. Preventive Services Task Force (USPSTF) has evaluated evidence for skin cancer screening; clinicians conducting targeted surveillance for high-risk older adults reference USPSTF guidance alongside AAD clinical practice guidelines (USPSTF Skin Cancer Recommendations).

  2. Diagnostic biopsy and pathologic classification — Lesions meeting clinical criteria undergo shave, punch, or excisional biopsy. Pathologic staging follows the American Joint Committee on Cancer (AJCC) classification system, distinguishing in situ from invasive disease and grading melanoma by Breslow thickness.

  3. Treatment — Treatment modality is matched to lesion type and patient-specific factors including comorbidity burden and medication interactions (relevant given polypharmacy considerations). Modalities include:

  4. Mohs micrographic surgery — highest cure rate for BCC and SCC in cosmetically or functionally critical sites; tissue-sparing approach well suited to elderly patients with limited healing reserve
  5. Excision with margins — standard for most primary melanoma and higher-risk SCC
  6. Cryotherapy and topical agents — used for actinic keratoses and superficial BCC

  7. Radiation therapy — a non-surgical option for patients with anticoagulation status or wound-healing contraindications; coordinated with elder oncology services for advanced disease

  8. Wound care and post-procedural management — Surgical sites in older adults require specialized wound management protocols. Slowed re-epithelialization, reduced collagen synthesis, and polypharmacy-associated healing impairment (notably corticosteroids and anticoagulants) extend recovery timelines and elevate infection risk.

Common scenarios

Actinic keratosis (AK) management — AKs are precancerous lesions caused by cumulative ultraviolet exposure. An estimated 58 million Americans have at least one AK (American Academy of Dermatology, Actinic Keratosis), with prevalence highest in adults over 60. Left untreated, a subset transform into invasive SCC. Field therapy with 5-fluorouracil cream, imiquimod, or photodynamic therapy addresses multiple lesions simultaneously.

Non-melanoma skin cancer (NMSC) excision — BCC and SCC together represent more than 5.4 million treatment cases annually in the United States, per AAD data. Older adults face higher recurrence risk, and immunosuppressed seniors — including organ transplant recipients — have a markedly elevated SCC burden requiring intensified surveillance.

Stasis ulcers and pressure injuries — Venous stasis ulcers and pressure injuries (pressure ulcers) overlap substantially with dermatologic practice. The National Pressure Injury Advisory Panel (NPIAP) maintains a four-stage classification system (NPIAP Staging) that governs clinical documentation, care planning, and Medicare reimbursement for wound treatment.

Drug-induced dermatoses — Polypharmacy generates dermatologic adverse effects including photosensitivity reactions, drug eruptions, and purpura. Thin atrophic skin in older adults amplifies injury severity from anticoagulant-associated purpura (actinic or senile purpura being distinct but visually similar).

Decision boundaries

Dermatologic care for older adults intersects with multiple clinical disciplines, and scope of service has defined boundaries:

Dermatology vs. primary care jurisdiction — Routine skin assessments often occur within elder primary care visits, but definitive biopsy, surgical excision, and advanced wound therapy require dermatology or surgical subspecialty involvement. Ambiguous pigmented lesions should not be managed expectantly in primary care beyond a single observation cycle.

Dermatology vs. wound care specialization — Complex wounds meeting criteria for specialized wound care centers fall under dedicated wound care protocols (elder wound care services), which may involve vascular surgery, podiatry, and hyperbaric oxygen therapy. Dermatologists retain primary jurisdiction over wound etiology determination and skin-specific dressing selection.

Telehealth boundaries — Teledermatology, recognized by CMS as a covered service under specific conditions, permits remote evaluation of photographed lesions but does not substitute for in-person biopsy. Elder telehealth services expand access for rural patients but carry documented limitations in lesion depth assessment.

Melanoma staging and oncology handoff — Any melanoma beyond Stage I (Breslow thickness > 1.0 mm or with ulceration or high mitotic rate per AJCC staging) warrants multidisciplinary evaluation with oncology. Sentinel lymph node biopsy thresholds and systemic therapy decisions fall outside dermatology's standalone scope.

Medicare-covered preventive screening boundaries — As of the CMS Physician Fee Schedule, full-body skin cancer screening is not a covered Medicare Annual Wellness Visit (AWV) component, though physicians may incorporate skin examination within the AWV at their discretion. Medically necessary visits for symptomatic or high-risk lesions are separately reimbursable under Part B (CMS Annual Wellness Visit overview).

Older adults with immunosuppression, a prior skin cancer diagnosis, or a history of significant cumulative sun exposure represent a high-surveillance category warranting annual full-body examination intervals, consistent with AAD position guidance.

References

Explore This Site

Regulations & Safety Regulatory References Tools & Calculators Bmi Health Metrics Calculator